Literature DB >> 2585035

Phase II trial of 5-fluorouracil and high-dose folinic acid in advanced renal cell cancer.

A Zaniboni1, E Simoncini, P Marpicati, E Montini, V Ferrari, G Marini.   

Abstract

Fourteen patients with metastatic renal cell carcinoma (RCC) were treated with high-dose folinic acid (HDFA): 200 mg/m2 i.v. and 5-fluorouracil (5-FU): 370 mg/m2 i.v. for 5 consecutive days every 28 days. Severe oral mucositis (WHO grade III-IV) was experienced by two patients, whereas hematological toxicity was mild. No complete or partial remission was observed. Short-lasting stable disease occurred in 8 patients (median = 5 months, range 2-11). This combination does not need further evaluation in patients with RCC.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2585035     DOI: 10.1080/1120009x.1989.11738921

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


  1 in total

1.  C-reactive Protein in Patients with Metastatic Clear Cell Renal Carcinoma: An Important Biomarker for Tumor-associated Inflammation.

Authors:  Albrecht Reichle; Jochen Grassinger; Klaus Bross; Jochen Wilke; Thomas Suedhoff; Bernhard Walter; Wolf-Ferdinand Wieland; Anna Berand; Reinhard Andreesen
Journal:  Biomark Insights       Date:  2007-02-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.